Medical Care Technologies(MDCE)
$0.00-0.00 (-25.93%)
MDCE
Medical Care Technologies financials statements
$0.00
At close:-0.00 (-25.93%)
Want to see MDCE full AI Analyst Report?
Medical Care Technologies (MDCE) Ratios
17 Followers
Medical Care Technologies Ratios
MDCE's free cash flow for Q2 2026 was $105.13K. For the 2026 fiscal year, MDCE's free cash flow was decreased by $-4.00 and operating cash flow was $105.13K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 |
|---|---|---|---|---|
| Liquidity Ratios | ||||
| Current Ratio | 70.69 | 17.87 | 8.69 | 8.43 |
| Quick Ratio | 18.44 | 1.82 | 8.69 | 8.43 |
| Cash Ratio | 10.42 | 0.64 | 0.51 | 0.10 |
| Solvency Ratio | 8.65 | 1.83 | -0.09 | 10.71 |
| Operating Cash Flow Ratio | 5.83 | -7.51 | 0.43 | 1.13 |
| Short-Term Operating Cash Flow Coverage | 15.55 | -9.10 | 0.76 | 5.00 |
| Net Current Asset Value | $ 1.86M | $ 1.38M | $ 533.98K | $ 921.49K |
| Leverage Ratios | ||||
| Debt-to-Assets Ratio | 0.01 | 0.05 | 0.06 | 0.03 |
| Debt-to-Equity Ratio | 0.01 | 0.05 | 0.07 | 0.03 |
| Debt-to-Capital Ratio | 0.01 | 0.05 | 0.07 | 0.03 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.01 | 1.06 | 1.13 | 1.13 |
| Debt Service Coverage Ratio | 13.74 | 2.18 | 0.00 | 47.54 |
| Interest Coverage Ratio | 32.49 | 58.70 | -58.75 | 0.00 |
| Debt to Market Cap | 0.01 | 0.01 | 0.01 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | -1.13 | 0.10 | 0.00 | 0.01 |
| Profitability Margins | ||||
| Gross Profit Margin | 53.75% | 49.03% | -7.82% | 38.34% |
| EBIT Margin | 22.21% | 23.31% | -52.05% | 31.69% |
| EBITDA Margin | 22.21% | 23.31% | 0.00% | 38.27% |
| Operating Profit Margin | 22.21% | 23.31% | -52.05% | 31.69% |
| Pretax Profit Margin | 21.53% | 22.91% | -52.94% | 31.69% |
| Net Profit Margin | 21.53% | 22.91% | -52.94% | 31.69% |
| Continuous Operations Profit Margin | 21.53% | 22.91% | -52.94% | 31.69% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 96.93% | 98.30% | 101.70% | 100.00% |
| Return on Assets (ROA) | 12.24% | 10.26% | -64.21% | 105.16% |
| Return on Equity (ROE) | 12.41% | 10.87% | -72.57% | 119.31% |
| Return on Capital Employed (ROCE) | 12.80% | 11.06% | -71.35% | 119.32% |
| Return on Invested Capital (ROIC) | 12.74% | 10.54% | -66.48% | 115.80% |
| Return on Tangible Assets | 12.24% | 10.26% | -64.21% | 105.16% |
| Earnings Yield | 17.75% | 2.46% | -6.00% | 12.23% |
| Efficiency Ratios | ||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 39.62 |
| Inventory Turnover | 0.36 | 0.25 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.57 | 0.45 | 1.21 | 3.32 |
| Working Capital Turnover Ratio | 0.66 | 0.68 | 1.01 | 0.00 |
| Cash Conversion Cycle | 1026.37 | 1436.04 | 0.00 | -9.21 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 1026.37 | 1436.04 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 9.21 |
| Operating Cycle | 1026.37 | 1436.04 | 0.00 | 0.00 |
| Cash Flow Ratios | ||||
| Operating Cash Flow Per Share | 0.00 | -0.00 | 0.00 | 0.00 |
| Free Cash Flow Per Share | 0.00 | -0.00 | 0.00 | 0.00 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | 0.00 | 0.00 | 46515.67 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | 0.00 | 46515.67 |
| Operating Cash Flow Coverage Ratio | 15.55 | -9.10 | 0.76 | 5.00 |
| Operating Cash Flow to Sales Ratio | 0.15 | -0.94 | 0.04 | 0.04 |
| Free Cash Flow Yield | 11.96% | -10.06% | 0.46% | 1.55% |
| Valuation Ratios | ||||
| Price-to-Earnings (P/E) Ratio | 4.00 | 40.72 | -16.67 | 8.17 |
| Price-to-Sales (P/S) Ratio | 1.21 | 9.33 | 8.82 | 2.59 |
| Price-to-Book (P/B) Ratio | 0.70 | 4.43 | 12.09 | 9.75 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 8.36 | -9.94 | 215.92 | 64.40 |
| Price-to-Operating Cash Flow Ratio | 8.36 | -9.94 | 215.91 | 64.40 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | -0.41 | 0.12 | 0.00 |
| Enterprise Value Multiple | 4.34 | 40.12 | 0.00 | 6.78 |
| Enterprise Value | 1.03M | 6.14M | 6.46M | 9.00M |
| EV to EBITDA | 4.34 | 40.12 | 0.00 | 6.78 |
| EV to Sales | 0.96 | 9.35 | 8.83 | 2.59 |
| EV to Free Cash Flow | 6.64 | -9.96 | 216.05 | 64.52 |
| EV to Operating Cash Flow | 6.64 | -9.96 | 216.04 | 64.52 |
| Tangible Book Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 |
| Shareholders’ Equity Per Share | 0.00 | 0.00 | 0.00 | 0.00 |
| Tax and Other Ratios | ||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | 0.00 | 0.00 | -0.00 | 0.00 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 0.97 | 0.98 | 1.02 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.32 | 0.26 | 0.44 | 0.07 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.67 | -4.10 | -0.08 | 0.13 |
Currency in USD
